Clinical Trials in Chicago

Showing 10301-10320 of 15,574 trials

FLU A+B Nasal Swab Clinical Study

NCT00636662

The purpose of this clinical study is to obtain clearance for the nasal swab sample type by demonstrating the performance characteristics of the FLU A+B Test versus standard laboratory culture for Influenza A and B viruses using nasal swab samples.

Influenza

Response Biomedical Corp.800 participantsStarted Feb 2008

Chicago, Illinois, United States • St Louis, Missouri, United States • Winston-Salem, North Carolina, United States +2 more locations

COMPLETEDPhase 22.2 miles

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis

NCT01904058

The study is a randomized, double-blind, placebo-controlled, multicenter study. It is a 13-week Phase 2 study in adults with primary biliary cirrhosis designed to compare the effect of daily dosing with UDCA in combination with LUM001 or placebo.

PBCPrimary Biliary Cirrhosis

Mirum Pharmaceuticals, Inc.66 participantsStarted Aug 2013

La Jolla, California, United States • Sacramento, California, United States • Miami, Florida, United States +21 more locations

FLU A+B Nasal Swab Clinical Study

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis

Find Trials by Condition in Chicago

Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

Promoting the Universal Medication Schedule Via Mobile and EHR Technologies

PRET: Patients Prone to Recurrence After Endovascular Treatment

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Observational Study of Surgical Treatment of Necrotizing Enterocolotis

Early Diagnosis of Candidiasis in Premature Infants

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

Whole-Body Cooling for Birth Asphyxia in Term Infants

Alternative Dosing Strategy of Ruxolitinib in Patients With Myelofibrosis

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)

Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer

Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment

Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction

Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth

LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer

PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)

A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas